NovaSom Home OSA Home Testing For UnitedHealthcare Plan Participants
NovaSom, Inc., the leader in obstructive sleep apnea (OSA) home testing and cost-containment solutions, has announced UnitedHealthcare plan participants now have access to NovaSom home sleep testing services for sleep apnea diagnosis. Home sleep testing is a clinically equivalent alternative to in-facility sleep testing that can be performed from the comfort and privacy of a patient’s home, at a fraction of the cost.
NovaSom will utilize its field-based provider relations team to educate physicians on appropriate screening parameters that will help identify clinically appropriate patients for home sleep testing. NovaSom will also make available a customized, provider-friendly workflow process aligned with prior authorization requirements to assure cost-effective diagnosis and initiation of treatment through its proprietary cloud-based MediTrack®System.
“OSA is one of the most serious and under-diagnosed medical problems in the United States, generating significant medical expense. Currently, an estimated 95 percent of OSA testing is performed in sleep labs, though research shows home sleep testing is clinically appropriate for up to 80 percent of patients,” said Richard Hassett, MD, CEO, NovaSom.“Patients and primary care physicians prefer the convenience, privacy, easy-access, accuracy and cost savings associated with NovaSom’s home sleep tests. We are pleased to partner with UnitedHealthcare, expanding our industry-leading national payer relationships and bringing convenient, affordable home testing to OSA sufferers nationwide.”
NovaSom is the industry leader in home sleep testing for OSA, with the first FDA-cleared device and over 10 years of experience in home sleep diagnostics. NovaSom’s home sleep testing technology monitors the five parameters recommended by the American Academy of Sleep Medicine (AASM) to diagnose OSA, and has been proven clinically equivalent to sleep lab studies in two peer-reviewed clinical publications. NovaSom is fully accredited by the Joint Commission as an Ambulatory Care Sleep Diagnostic Center and is CMS approved as an Independent Diagnostic Testing Facility.
Obstructive Sleep Apnea (OSA) affects an estimated 18 million Americans. However, a startling 85 percent of sufferers are undiagnosed and untreated, generating significant clinical complications and medical expense for patients and the healthcare system. Nearly half of all OSA patients also suffer from one or more serious health conditions such as diabetes, hypertension or heart failure that is either aggravated or caused by OSA. Treating OSA reduces medical expenses, improves patient quality of life and lowers associated health risks.
Tagged with: Home Sleep Apnea Testing • Home Sleep Test • Home Sleep Testing • MediTrack system • NovaSom home sleep testing services • obstructive sleep apnea (OSA) home testing • OSA Testing • Sleep Apnea • Sleep Apnea Diagnosis • Sleep Center • Sleep Lab
Filed under: Home Test Devices • Obstructive Sleep Apnea • Sleep • Sleep Apnea • Sleep Apnea Awareness • Sleep Apnea Devices • Sleep Apnea Diagnosis • Sleep Apnea Equipments • Sleep Apnea Events • Sleep Apnea Markets • Sleep Apnea News • Sleep Apnea Test • Sleep Apnea Treatment • Sleep Center • Sleep Disorders • Sleep Lab • Sleep Problems • Sleep Study
Like this post? Subscribe to my RSS feed and get loads more!